Please assess the completion status of the following clinical trial:

Trial Title: Anti-inflammatory Cells in Peritoneal Cavity

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* woman over 18 year old undergoing exploration of ovarian cysts by coelioscopy~* patient with chronic renal insufficiency undergoing peritoneal dialysis~* informed consent obtained~Exclusion criteria:~* pregnancy or breast-feeding~* non affiliation to health care insurance~* treatment with corticosteroids over 15 mg/day~* treatment with rituximab

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- subjects with ovarian cyst (Type: OTHER): Peritoneal fluid sample obtained from coelioscopy for exploration of ovarian cysts and blood sample
- subjects with peritoneal dialysis (Type: OTHER): Peritoneal fluid sample obtained from peritoneal dialysis fluid of patients with chronic renal insufficiency and blood sample

Based on this trial design, predict the completion outcome and termination type (if applicable).